SOW
IONS icon

State of Wyoming’s Ionis Pharmaceuticals IONS Stock Holding History

State of Wyoming’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
+2,024
New +$152K 0.02% 1148
2022
Q4 		– Sell
-1,338
Closed -$59K – 1663
2022
Q3 		$59K Buy
+1,338
New +$56.4K 0.03% 924

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State of Wyoming's IONS Position: Q2 2026 in Review

State of Wyoming opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 2,024 shares worth $160K. The stake represents 0.02% of the portfolio and ranks #1148 among its holdings. This is a return to the name: State of Wyoming previously reported a position in IONS as recently as Q3 2022.

State of Wyoming first reported a position in IONS in Q3 2022 and has held it in 2 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • State of Wyoming held 2,024 shares of Ionis Pharmaceuticals worth $160K as of Q2 2026.
  • Ionis Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1148 holding.
  • State of Wyoming first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 2 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.